The difference between effective dosing and throwing money into subcutaneous fat comes down to understanding molarity, concentration math, and the biological ceiling at which NNMT inhibition plateaus
Why the Prescribing Workflow Is the Bottleneck The clinical knowledge exists
This matters because no employer population is the same
References Corona G, Giagulli VA, Maseroli E, et al
Works cited GLP-1 and Appetite Control: How it Works and Why it's Effective - Westlake Dermatology, accessed April 22, 2025, Role of GLP-1 Receptor Agonists for Weight Loss - YouTube, accessed April 22, 2025, Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists - PubMed Central, accessed April 22, 2025, Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks, accessed April 22, 2025, How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss
They may be prescribed for people with obesity